OBI Pharma, Inc. financial statements
OBI Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | TWD 58.58M | EODHD |
| Net income | −TWD 2.05B | EODHD |
| Cash and equivalents | TWD 759.33M | EODHD |
OBI Pharma, Inc. financials on 6ix · OBI Pharma, Inc. on 6ix